Pharmacologically targeting CDK12 induces BRCAness and synergizes with merestinib to exacerbate DNA damage in high-risk neuroblastoma
- DOI
- 10.1016/j.celrep.2026.117997
- Published
- 2026-10
- Container
- Cell Reports
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.celrep.2026.117997,
title = {Pharmacologically targeting CDK12 induces BRCAness and synergizes with merestinib to exacerbate DNA damage in high-risk neuroblastoma},
author = {Joshua Robert Goulding and Stijn Tim Couwenbergh and Sarah-Lee Bekaert and Ellen Sanders and Fanny De Vloed and Vicky Amo-Addae and Aline Eggermont and Jolien De Wyn and Kaat De Wever and Lasse Vleminckx and Selma Eising and Jan J. Molenaar and Marlinde L. van den Boogaard and Lisa Depestel and Kaat Durinck},
year = {2026},
journal = {Cell Reports},
doi = {10.1016/j.celrep.2026.117997},
url = {https://doi.org/10.1016/j.celrep.2026.117997}
}RIS
TY - JOUR TI - Pharmacologically targeting CDK12 induces BRCAness and synergizes with merestinib to exacerbate DNA damage in high-risk neuroblastoma AU - Joshua Robert Goulding AU - Stijn Tim Couwenbergh AU - Sarah-Lee Bekaert AU - Ellen Sanders AU - Fanny De Vloed AU - Vicky Amo-Addae AU - Aline Eggermont AU - Jolien De Wyn AU - Kaat De Wever AU - Lasse Vleminckx AU - Selma Eising AU - Jan J. Molenaar AU - Marlinde L. van den Boogaard AU - Lisa Depestel AU - Kaat Durinck PY - 2026 JO - Cell Reports DO - 10.1016/j.celrep.2026.117997 UR - https://doi.org/10.1016/j.celrep.2026.117997 ER -
APA
Goulding, J. R., Couwenbergh, S. T., Bekaert, S., Sanders, E., Vloed, F. D., Amo-Addae, V., Eggermont, A., Wyn, J. D., Wever, K. D., Vleminckx, L., Eising, S., Molenaar, J. J., Boogaard, M. L. V. D., Depestel, L., & Durinck, K. (2026). Pharmacologically targeting CDK12 induces BRCAness and synergizes with merestinib to exacerbate DNA damage in high-risk neuroblastoma. Cell Reports. https://doi.org/10.1016/j.celrep.2026.117997
Source records
- crossref · retrieved 2026-11-07T18:31:11.856Z